Sign up
Pharma Capital

hVIVO PLC refocused and on the path to profitability

hVIVO PLC's (LON:HVO) executive chairman Dr Trevor Phillips chats to Proactive London following the release of their 2018 results.

Philips says it's been a year of change and he's confident they'll be in a position to turn a profit next year.

He adds their pipeline of opportunities for 2020 is already looking exceptionally strong.

 

View full HVO profile View Profile
Newswire

hVIVO targeting profitability in 2020

View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.